Research Alliance Corp. III (RACC) Prices $75M IPO
Research Alliance Corp. III (NASDAQ:RACC) announced the pricing of its $75 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “RACC” on Tuesday, May 19, 2026.
The new SPAC intends to combine with a target company in the healthcare or healthcare-related industries.
Research Alliance Corp. III is to be led by Chief Executive Officer Matthew Hammond, Ph.D., Chief Business Officer and Chief Operating Officer Henry Stusnick and Chief Financial Officer Fran Adams. Michael MacLean and Timothy J. Miller, Ph.D. will serve on its Board of Directors.
Total SPAC deal count for 2026 year-to-date is now 91. This offering is expected to close on Wednesday, May 20, 2026.
Leerink Partners is acting as the sole book-running manager of the offering. Cooley LLP is serving as Issuer’s Counsel with Kirkland & Ellis LLP serving as Underwriter’s Counsel. CBIZ CPAs, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
